Deciphering influenza B virus-derived peptides and their presentation by HLA class I molecules
Biochemical Society Transactions · 26.08.2026 · 54 (8) · 1021-1052
DOI: 10.1042/bst20260075 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Biochemical Society Transactions, online erschienen am 31.07.2026. Verfasst von Janesha C Maddumage und 6 weiteren Autor:innen. Beteiligte Einrichtung: Infection and Immunity Program, La Trobe Institute for Molecular Science (LIMS), La Trobe University, Bundoora, Victoria 3086, Australia. Hauptthemen laut MEDLINE: Histocompatibility Antigens Class I, Influenza B virus, Peptides, Antigen Presentation. Die Arbeit nennt 63 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Australian Government (Federal Government), DHAC | National Health and Medical Research Council (NHMRC), LTU | La Trobe Institute for Molecular Science, La Trobe University (LIMS).
Abstract (Originalsprache)
Despite influenza vaccines being widely available, influenza still causes significant morbidity and mortality annually. Vaccines typically induce humoral-mediated protection against rapidly mutating surface glycoproteins, necessitating that they be updated and administered each year. In contrast, CD8+ T cells, which can control and clear viral infections, can recognise more conserved viral epitopes. Therefore, there is considerable interest in understanding CD8+ T cell responses to influenza virus for the development of future vaccines and therapeutics. Although Alphainfluenzavirus influenzae (FLUAV) and Betainfluenzavirus influenzae (FLUBV) co-circulate in humans and both contribute to seasonal epidemics, there is limited data regarding CD8+ T cell responses to FLUBV. This knowledge gap spans both immunological and molecular insights. In the present review, we summarise the current knowledge of FLUBV-derived CD8+ T cell epitopes at both cellular and molecular levels, in comparison with FLUAV. Collectively, this highlights the limited data available on FLUBV, despite its significant role in human influenza infections.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Infection and Immunity Program, La Trobe Institute for Molecular Science (LIMS), La Trobe University, Bundoora, Victoria 3086, Australia.
- Department of Biochemistry and Chemistry, School of Agriculture, Biomedicine and Environment (SABE), La Trobe University, Bundoora, Victoria 3086, Australia.
- Department of Biochemistry and Molecular Biology, Biomedicine Discovery Institute, Monash University, Clayton, Victoria 3800, Australia.
ORCID-Profile: Emma J Grant, Stephanie Gras
Förderung
- Australian Government (Federal Government)
- DHAC | National Health and Medical Research Council (NHMRC)
- LTU | La Trobe Institute for Molecular Science, La Trobe University (LIMS)
Zitieren
APA
Maddumage, J. C., Dow, G. R., Murdolo, L. D., Liwei Leong, S., Chatzileontiadou, D. S. M., Grant, E. J., & Gras, S. (2026). Deciphering influenza B virus-derived peptides and their presentation by HLA class I molecules. Biochemical Society Transactions, 54(8), 1021-1052. https://doi.org/10.1042/bst20260075
Vancouver
Maddumage JC, Dow GR, Murdolo LD, Liwei Leong S, Chatzileontiadou DSM, Grant EJ, et al. Deciphering influenza B virus-derived peptides and their presentation by HLA class I molecules. Biochemical Society Transactions. 2026;54(8):1021-1052. doi:10.1042/bst20260075
BibTeX
@article{Maddumage2026,
author = {Maddumage, Janesha C and Dow, Georgia R and Murdolo, Lawton D and Liwei Leong, Samuel and Chatzileontiadou, Demetra S M and Grant, Emma J and Gras, Stephanie},
title = {Deciphering influenza B virus-derived peptides and their presentation by HLA class I molecules},
journal = {Biochemical Society Transactions},
year = {2026},
volume = {54},
number = {8},
pages = {1021--1052},
doi = {10.1042/bst20260075}
}
EUVIMED